411 related articles for article (PubMed ID: 33527763)
1. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.
Reder H; Wagner S; Gamerdinger U; Sandmann S; Wuerdemann N; Braeuninger A; Dugas M; Gattenloehner S; Klussmann JP; Wittekindt C
Oral Oncol; 2019 Jun; 93():59-65. PubMed ID: 31109697
[TBL] [Abstract][Full Text] [Related]
4. HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.
Faden DL; Langenbucher A; Kuhs K; Lewis JS; Mirabello L; Yeager M; Boland JF; Bass S; Steinberg M; Cullen M; Lawrence MS; Ferris RL
Carcinogenesis; 2021 Feb; 42(1):14-20. PubMed ID: 33075810
[TBL] [Abstract][Full Text] [Related]
5. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
[TBL] [Abstract][Full Text] [Related]
6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
7. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
[TBL] [Abstract][Full Text] [Related]
8. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
9. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
10. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
12. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
[TBL] [Abstract][Full Text] [Related]
13. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
[TBL] [Abstract][Full Text] [Related]
14. Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
Grønhøj C; Jensen DH; Agander T; Kiss K; Høgdall E; Specht L; Bagger FO; Nielsen FC; von Buchwald C
BMC Cancer; 2018 Jun; 18(1):640. PubMed ID: 29879932
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.
Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I
Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971
[TBL] [Abstract][Full Text] [Related]
16. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
17. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
[TBL] [Abstract][Full Text] [Related]
20. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
